A New Paradigm for Long-Term Weight Management: Once-Monthly Bofanglutide Maintenance Therapy Delivers Positive Results in Weight Control and Maintenance Over 24 Weeks -- Gan & Lee Pharmaceuticals' GRADUAL-3 Study Meets Its Primary Endpoint

Yerel otomatik çeviri · Kaynağın orijinal dili

Özet

BEIJING and BRIDGEWATER, Mass., Nov. 4, 2026 — Gan & Lee Pharmaceuticals (Stock Code: 603087.

Kaynağın orijinal dili: PR Newswire UK — News ReleasesOrijinal duyuruyu açın →

İlgili şirketler

Konuları keşfedin